• Decrease font size
  • Default font           size
  • Increase font size
Latest News from Prosonix
Prosonix Launches New SAX Technology PDF Print E-mail
Tuesday, 19 December 2006 12:53
Prosonix Limited (Oxford, UK) is delighted to announce an agreement with the University of Bath (Bath, UK) for the exclusive commercialisation of the University’s unique sonocrystallization particle engineering technology Solution Atomisation and Crystallization by Sonication (SAXTM). The agreement builds on 18 months of initial collaboration and technology evaluation between the parties.
Last Updated on Sunday, 18 January 2009 19:41
 
<< Start < Prev 1 2 3 Next > End >>

Page 3 of 3

Latest News

03 Feb 2012 - Geoff Down appointed as Chief Medical Officer
Prosonix Appoints Respiratory Drug Development Expert Dr Geoff Down as Chief Medical Officer Prosonix (Oxford, UK), an emerging pharmaceutical company developing a portfolio of enhanced respiratory...
More in: Latest

Events

Respiratory Drug Delivery 2012
10 October 2011 08:57
article thumbnai